Drug General Information
Drug ID	D02AFZ
Former ID	DNC014322
Drug Name	2-Propyl-beta-carboline-2-ium iodide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530824]
Structure		Download 2D MOL 3D MOL
Formula	C14H15IN2
Canonical SMILES	CCC[N+]1=CC2=C(C=C1)C3=CC=CC=C3N2.[I-]
InChI	1S/C14H14N2.HI/c1-2-8-16-9-7-12-11-5-3-4-6-13(11)15-14(12)10-16;/h3-7,9-10H,2,8H2,1H3;1H
InChIKey	MUASLNFMPGFPJA-UHFFFAOYSA-N
PubChem Compound ID	46889203
Target and Pathway
Target(s)	Cholinesterase	Target Info	Inhibitor	[530824]
	Acetylcholinesterase	Target Info	Inhibitor	[530824]
KEGG Pathway	Glycerophospholipid metabolism
	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Irinotecan PathwayWP727:Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer Pathway
References
Ref 530824	J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Ref 530824	J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.